Melatonin API Market to Surge at 18.0% CAGR, Reaching US$ 12,450.2 Million by 2034 | Fact.MR Report

Melatonin API Market to Surge at 18.0% CAGR, Reaching US$ 12,450.2 Million by 2034 | Fact.MR Report

Melatonin API market size is estimated to be US$ 2,371.9 million in 2024. Growth is anticipated to expand at a high CAGR of 18.0% during the period 2024-2034. Projected growth will drive the market to a strong size of US$ 12,450.2 million during 2034. Growing knowledge of the importance of melatonin in sleep management is driving market growth.

The past years have witnessed an unprecedented increase in the demand for sleep-inducing supplements, particularly among the young population. This has compelled pharma companies to innovate and create new products, including those comprising melatonin API, to target this emerging market. The consumer demand for melatonin API is also increasing due to its assumed natural and holistic method of sleeping.

Melatonin API has its uses in the pharmaceutical, nutraceutical, and cosmetic industries because of its diverse properties. In the nutraceutical industry, melatonin API is used to create dietary supplements intended to aid different aspects of health and wellness. Its use in the cosmetic industry is also rising because melatonin API has antioxidant properties.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9571

Key Takeaways from Market Study:

The melatonin API market is estimated to be valued at US$ 2,371.9 million in 2024 and is projected to grow at a robust CAGR of 18.0%, reaching a market size of US$ 12,450.2 million by 2034, driven by increasing demand for sleep disorder treatments and expanding applications in pharmaceuticals.
The GMP (Good Manufacturing Practice) segment is expected to witness exceptional growth of 92.50% from 2024 to 2034, as regulatory compliance and quality standards become more stringent in pharmaceutical production.
The clinical use segment is forecasted to expand at a remarkable growth rate of 83.40% during the forecast period, fueled by rising clinical trials and increasing adoption of melatonin-based therapies for various medical conditions.
In terms of regional market distribution, North America is projected to hold a dominant share of 43.80% in 2024, supported by high consumer awareness, a well-established pharmaceutical industry, and growing demand for sleep aid supplements.
The East Asia market is expected to account for 18.00% of the global market share in 2024, reflecting significant growth opportunities driven by increasing healthcare investments, rising cases of sleep disorders, and expanding pharmaceutical manufacturing capabilities in the region.

Leading Players Driving Innovation in the Melatonin API Market:

Merck KGaA; Caesar & Loretz GmbH; EVONIK; Bio-Techne Corp.; Cayman Chemical Company (Matreya); Spectrum Chemical; Caesar & Loretz GmbH; LGM Pharma; Flavine Europe GmbH; Ralington Pharma LLP; Simson Pharma Limited; Santa Cruz Biotechnology, Inc.; Biosynth; Otto Chemie Pvt. Ltd.; Pharmaffiliates Analytics and Synthetics P. Ltd.; Clearsynth Labs

Which are the drivers of global melatonin API demand surge?

Over thirty percent of adults receive less than six hours of sleep per night, as indicated by the American Sleep Association in a recent study. This has resulted in an increase in the number of cases of sleep disorders among the general population, greatly raising the demand for melatonin API in the pharma and healthcare sector because it assists in the regulation of sleeping cycles and enhances sleeping quality.

Apart from this, there also has been a significant thrust towards nutraceuticals, with emphasis on natural and alternative health options. Melatonin API, being a natural hormone, is an ideal option for people looking for effective health solutions for sleep disorders. Their demand from the general public is also shooting through the roof due to the active promotional efforts by fitness experts, healthcare professionals, and nutritionists on social media platforms.

Browse Full Report: https://www.factmr.com/report/melatonin-api-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global melatonin API market, presenting historical data for 2019 to 2023 and forecast statistics for 2024 to 2034.

The Melatonin API Market is segmented based on source, grade, application, and region. By source, the market is categorized into natural, synthetic, and bio-synthetic, with synthetic melatonin being widely used due to its cost-effectiveness and scalability.

Based on grade, the market is divided into GMP and non-GMP, where GMP-grade melatonin APIs dominate due to stringent regulatory requirements for pharmaceutical applications. In terms of application, the market is segmented into clinical and research, with the clinical segment experiencing significant growth due to the rising use of melatonin in sleep disorder treatments and other medical applications.

Geographically, the market is analyzed across North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA), with North America leading in market share due to high consumer demand and well-established pharmaceutical infrastructure, while Asia Pacific is witnessing rapid expansion due to increasing healthcare investments and manufacturing capabilities.

Check out More Related Studies Published by Fact.MR Research:

Wearable Medication Adherence Tracker Market - https://www.factmr.com/report/wearable-medication-adherence-tracker-market

Biohacking Market - https://www.factmr.com/report/biohacking-market

Softgel Capsules Market - https://www.factmr.com/report/softgel-capsules-market

Drug Delivery Systems Market - https://www.factmr.com/report/4768/drug-delivery-systems-market

Drug Discovery Services Market - https://www.factmr.com/report/375/drug-discovery-services-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.